HK1124068A1 - 2-arylindole derivatives as mpges-1 inhibitors - Google Patents

2-arylindole derivatives as mpges-1 inhibitors

Info

Publication number
HK1124068A1
HK1124068A1 HK09104184.9A HK09104184A HK1124068A1 HK 1124068 A1 HK1124068 A1 HK 1124068A1 HK 09104184 A HK09104184 A HK 09104184A HK 1124068 A1 HK1124068 A1 HK 1124068A1
Authority
HK
Hong Kong
Prior art keywords
mpges
inhibitors
arylindole derivatives
arylindole
derivatives
Prior art date
Application number
HK09104184.9A
Other languages
English (en)
Inventor
Maria Alessandra Alisi
Nicola Cazzolla
Barbara Garofalo
Guido Furlotti
Caterina Maugeri
Rosella Ombrato
Isabella Coletta
Lorenzo Polenzani
Giorgina Mangano
Beatrice Garrone
Angelo Guglielmotti
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1124068A1 publication Critical patent/HK1124068A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
HK09104184.9A 2006-07-14 2009-05-06 2-arylindole derivatives as mpges-1 inhibitors HK1124068A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001368A ITMI20061368A1 (it) 2006-07-14 2006-07-14 Composto 2-arilindolico sostituito in posizione 5, composizione farmaceutica che lo comprende nonche' composti intermedi e procedimento per prepararlo
PCT/EP2007/055901 WO2008006663A1 (en) 2006-07-14 2007-06-14 2-arylindole derivatives as npges-i inhibitors

Publications (1)

Publication Number Publication Date
HK1124068A1 true HK1124068A1 (en) 2009-08-07

Family

ID=37895798

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09104184.9A HK1124068A1 (en) 2006-07-14 2009-05-06 2-arylindole derivatives as mpges-1 inhibitors

Country Status (22)

Country Link
US (1) US8017644B2 (xx)
EP (1) EP2049480B1 (xx)
JP (1) JP5302191B2 (xx)
KR (2) KR101440015B1 (xx)
CN (1) CN101490000B (xx)
AR (1) AR061973A1 (xx)
AU (1) AU2007271865B2 (xx)
BR (1) BRPI0712889A8 (xx)
CA (1) CA2655750C (xx)
DK (1) DK2049480T3 (xx)
EA (1) EA015689B1 (xx)
ES (1) ES2441594T3 (xx)
GE (1) GEP20115166B (xx)
HK (1) HK1124068A1 (xx)
IL (1) IL196000A (xx)
IT (1) ITMI20061368A1 (xx)
MX (1) MX2009000492A (xx)
PL (1) PL2049480T3 (xx)
PT (1) PT2049480E (xx)
SI (1) SI2049480T1 (xx)
UA (1) UA96759C2 (xx)
WO (1) WO2008006663A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2078711A1 (en) 2007-12-28 2009-07-15 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
AU2010232729A1 (en) 2009-03-31 2011-10-20 Arqule, Inc. Substituted indolo-pyridinone compounds
WO2011077313A1 (en) 2009-12-22 2011-06-30 Pfizer Inc. Piperidinecarboxamides as mpges - 1 inhibitors
CN103857657B (zh) 2011-08-18 2016-04-20 日本新药株式会社 杂环衍生物及医药
WO2013038308A1 (en) * 2011-09-15 2013-03-21 Glenmark Pharmaceuticals S.A. SUBSTITUTED BICYCLIC HETEROARYL COMPOUNDS AS mPGES-1 INHIBITORS
RU2681537C2 (ru) * 2014-04-14 2019-03-07 Шанхай Хэнжуй Фармасьютикал Ко., Лтд. Амидные производные и их фармацевтически приемлемые соли, способ их получения и медицинское применение
EP3178810A4 (en) * 2014-08-08 2018-07-04 Kasuma Partners Inc. Condensed heterocyclic compound
IL277071B1 (en) 2018-03-08 2024-03-01 Incyte Corp Aminopyrizine diol compounds as PI3K–y inhibitors
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
KR20210024983A (ko) * 2019-08-26 2021-03-08 국제약품 주식회사 인돌 카복사미드 유도체 및 그를 포함하는 약제학적 조성물
US11807644B2 (en) 2020-05-12 2023-11-07 Pmv Pharmaceuticals, Inc. Methods and compounds for restoring mutant p53 function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003270426A1 (en) * 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
WO2004069788A1 (ja) * 2003-02-07 2004-08-19 Ono Pharmaceutical Co., Ltd. カルボン酸化合物
ES2441206T3 (es) 2003-09-03 2014-02-03 Raqualia Pharma Inc. Compuestos de fenil o piridilamida como antagonistas de la prostaglandina E2
ITTO20040125A1 (it) * 2004-03-01 2004-06-01 Rotta Research Lab Nuove amidine eterocicliche inibitrici la produzione di ossido d'azoto (no) ad attivita' antinfiammatoria ed analgesica
GB0410121D0 (en) * 2004-05-06 2004-06-09 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
SI2049480T1 (sl) 2014-02-28
WO2008006663A1 (en) 2008-01-17
AR061973A1 (es) 2008-08-10
AU2007271865A1 (en) 2008-01-17
KR20140091569A (ko) 2014-07-21
GEP20115166B (en) 2011-02-25
KR20090054962A (ko) 2009-06-01
US20090186922A1 (en) 2009-07-23
KR101440015B1 (ko) 2014-09-12
DK2049480T3 (da) 2014-01-20
EA200970124A1 (ru) 2009-06-30
JP5302191B2 (ja) 2013-10-02
US8017644B2 (en) 2011-09-13
ES2441594T3 (es) 2014-02-05
ITMI20061368A1 (it) 2008-01-15
EP2049480B1 (en) 2013-10-30
MX2009000492A (es) 2009-01-27
AU2007271865B2 (en) 2013-02-21
UA96759C2 (xx) 2011-12-12
CN101490000B (zh) 2012-10-03
BRPI0712889A2 (pt) 2012-10-09
EA015689B1 (ru) 2011-10-31
IL196000A0 (en) 2009-09-01
CN101490000A (zh) 2009-07-22
EP2049480A1 (en) 2009-04-22
BRPI0712889A8 (pt) 2018-01-02
JP2009543766A (ja) 2009-12-10
CA2655750C (en) 2014-09-09
CA2655750A1 (en) 2008-01-17
PL2049480T3 (pl) 2014-03-31
PT2049480E (pt) 2013-12-16
IL196000A (en) 2013-10-31

Similar Documents

Publication Publication Date Title
IL198247A0 (en) Indazole derivatives useful as l-cpt1 inhibitors
ZA200807748B (en) Dihydropyrazolopyrimidinone derivatives
HK1134284A1 (en) Pyridizinone derivatives pyridizinone
IL193641A0 (en) Spiroindolinone derivatives
IL195013A0 (en) Pyridopyrimidinone derivatives
EP1973405A4 (en) HYDROXYALKYMARYLAMIDE DERIVATIVES
IL198319A0 (en) Spiroindolinone derivatives
IL195422A0 (en) 2-pyrazinecarboxamide derivatives
ZA200805574B (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
HK1124068A1 (en) 2-arylindole derivatives as mpges-1 inhibitors
PL2078001T3 (pl) Pochodne diazepano-acetamidowe jako selektywne inhibitory 11-hsd1
IL195287A0 (en) 2-thioxanthine derivatives acting as mpo-inhibitors
IL198059A0 (en) 2-aminocarbonyl-pyridine derivatives
IL196364A0 (en) Aminoindazolylurea derivatives
HK1136276A1 (en) 5-hydroxymethyl-oxazolidin-2-one derivatives 5---2-
IL193211A0 (en) Indazole-heteroaryl derivatives
IL197152A0 (en) 5-phenyl-nicotinamide derivatives
EP2043633A4 (en) THIADIAZOLIDINONDERIVATE
GB0622472D0 (en) Novel heterocyclic derivatives
IL197239A0 (en) Phenyloxyaniline derivatives
ZA200807460B (en) Spiroindolinone derivatives
GB0614154D0 (en) Novel Pyriazine Derivatives
GB0610019D0 (en) Benzotriazepinone derivatives
GB0610018D0 (en) Benzotriazepinone derivatives
IL198973A0 (en) Sulfamatobenzothiophene derivatives

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180614